Quick Answer
BIO-TECHNE Corp reported Operating Income of $102.25 million for fiscal year 2025.
BIO-TECHNE Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $102.25M | -50.5% |
| 2024 | $206.69M | -30.9% |
| 2023 | $298.94M | +0.8% |
| 2022 | $296.59M | +25.0% |
| 2021 | $237.30M | +50.7% |
| 2020 | $157.42M | +7.3% |
| 2019 | $146.72M | +7.7% |
| 2018 | $136.18M | +12.9% |
| 2017 | $120.58M | -19.9% |
| 2016 | $150.59M | +2.4% |
| 2015 | $147.02M | +91933.2% |
| 2014 | $159.8K | +0.8% |
| 2013 | $158.5K | -99.9% |
| 2012 | $166.21M | +1.9% |
| 2011 | $163.06M | +4.3% |
| 2010 | $156.33M | +3.7% |
| 2009 | $150.78M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $54.46M | +14.9% | +14.3% |
| September 30, 2025 | $47.66M | +19.2% | +23.1% |
| March 31, 2025 | $38.71M | -42.2% | -18.4% |
| December 31, 2024 | $47.42M | +24.8% | +18.6% |
| September 30, 2024 | $39.99M | -28.4% | -40.3% |
| March 31, 2024 | $67.00M | -16.5% | +76.3% |
| December 31, 2023 | $38.00M | -44.0% | -32.0% |
| September 30, 2023 | $55.86M | -0.8% | -30.4% |
- BIO-TECHNE Corp showed a decrease of -50.5% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, BIO-TECHNE Corp’s operating income has declined by 32.2% (from $150.78 million to $102.25 million).
- The most recent figure is from BIO-TECHNE Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: